Evidence shows that IL-22 can directly modulate lipid metabolism by promoting lipolysis and enhancing fatty acid β-oxidation in adipose tissue and hepatocytes of obese mice, thus attenuating obesity-associated fatty liver and steatosis [27,52]. Here, IL22 is linked to obesity due to melanocortin 4 receptor deficiency.